Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02059980 · ClinicalTrials.gov registry record · NA
Developing Effective Response Inhibition Training for Symptom Relief in OCD and Trichotillomania
A NA study, sponsored by University of Wisconsin, Milwaukee.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02059980 is a NA study that has completed, run by University of Wisconsin, Milwaukee. The registered enrollment target is 45 participants.
The verdict
NCT02059980, a NA study, has completed, sponsored by University of Wisconsin, Milwaukee.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
Obsessive-compulsive disorder (OCD) and its related disorders (e.g., trichotillomania) are characterized by the marked difficulty in inhibiting unwanted or inappropriate responses. There is compelling evidence that poor response inhibition is a core cognitive feature of OCD and its related disorders, but no effective intervention exists that directly attempts to address this problematic cognitive deficiency. This study will examine the feasibility and clinical utility of a computerized cognitive training program designed to improve response inhibition among individuals diagnosed with OCD or trichotillomania.This training program offers systematic practice of response inhibition in the form of a 40-level computer game. Individuals with these conditions will be randomized to either 8 sessions of (a) computerized response inhibition training (RIT) or (b) placebo computer training (PLT). We hypothesize that RIT will outperform PLT in improving response inhibition capabilities and reducing relevant clinical symptoms. In sum, this project is expected to generate important knowledge to guide the development of effective computer-based treatment approaches that may help reduce critical problems of existing treatments such as suboptimal patient retention and treatment under-utilization, thereby improving overall treatment response rates among individuals suffering from OCD and related conditions.
Interventions
- BEHAVIORAL Response inhibition training
- BEHAVIORAL Placebo Control Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2014-08 |
| Est. Completion | 2017-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02059980
The ClinicalTrials.gov registry entry for NCT02059980 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Milwaukee, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Response inhibition training is the first listed.
NCT02059980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02059980 about?
NCT02059980 is a clinical study titled "Developing Effective Response Inhibition Training for Symptom Relief in OCD and Trichotillomania". Obsessive-compulsive disorder (OCD) and its related disorders (e.g., trichotillomania) are characterized by the marked difficulty in inhibiting unwanted or inappropriate responses. There is compelling evidence that poor response inhibition is a core cognitive feature of OCD and its related disorders...
What is the current status of trial NCT02059980?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2014-08. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02059980?
The interventions under investigation include: Response inhibition training (BEHAVIORAL), Placebo Control Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02059980?
This trial is sponsored by University of Wisconsin, Milwaukee, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.